Skip to main content
Top
Published in: Intensive Care Medicine 3/2010

01-03-2010 | Experimental

The impact of crystalloid and colloid infusion on the kidney in rodent sepsis

Authors: Martin Alexander Schick, Tobias Jobst Isbary, Nicolas Schlegel, Juergen Brugger, Jens Waschke, Ralf Muellenbach, Norbert Roewer, Christian Wunder

Published in: Intensive Care Medicine | Issue 3/2010

Login to get access

Abstract

Purpose

Volume replacement remains one of the pillars of sepsis therapy. The effect of different volume solutions on kidney function in sepsis still remains unclear. We therefore determined the impact of crystalloid and colloid solutions on kidney function in a rodent model of abdominal sepsis induced by cecal ligation and puncture (CLP).

Methods

Anesthetized rats underwent the CLP procedure, whereas control animals were sham operated. Septic animals were treated with crystalloid and colloid solutions. Hemodynamic variables and blood gases were measured. After 24 h animals were re-anesthetized, the kidneys were harvested, and creatinine (crea), urea, cystatin C and neutrophil gelatinase-associated lipocalin (NGAL) were investigated.

Results

Septic animals exhibited a mortality rate of 19% after 24 h. Gelatin-treated animals showed significantly increased levels of crea and urea. Colloids [gelatin 4% (Gel) or hydroxyethyl starch 6% 130/0.4 (HES)] as volume replacement resulted in elevated levels of NGAL. The histopathological observations revealed that Gel- and HES-treated animals showed vesicles within epithelial cells of the tubulus system and an overall increased injury. In contrast, total injury scores in groups treated with crystalloids [0.9% NaCl (NaCl) and Sterofundin® ISO (SteroIso)] were not significantly different compared to sham-treated animals.

Conclusion

None of the examined volume solution was inert to the kidney. In a CLP rodent sepsis model, animals infused with balanced crystalloid SteroIso exhibited the least effects on kidney function. Both hydroxyethyl starch 6% 130/0.4 and gelatin 4% derogated the kidney, whereas gelatin was more harmful when compared with hydroxyethyl starch.
Literature
1.
go back to reference Hotchkiss RS, Karl IE (2003) The pathophysiology and treatment of sepsis. N Engl J Med 348:138–150CrossRefPubMed Hotchkiss RS, Karl IE (2003) The pathophysiology and treatment of sepsis. N Engl J Med 348:138–150CrossRefPubMed
2.
go back to reference Sakr Y, Payen D, Reinhart K, Sipmann FS, Zavala E, Bewley J, Marx G, Vincent JL (2007) Effects of hydroxyethyl starch administration on renal function in critically ill patients. Br J Anaesth 98:216–224CrossRefPubMed Sakr Y, Payen D, Reinhart K, Sipmann FS, Zavala E, Bewley J, Marx G, Vincent JL (2007) Effects of hydroxyethyl starch administration on renal function in critically ill patients. Br J Anaesth 98:216–224CrossRefPubMed
3.
go back to reference Trof RJ, Di Maggio F, Leemreis J, Groeneveld AB (2006) Biomarkers of acute renal injury and renal failure. Shock 26:245–253CrossRefPubMed Trof RJ, Di Maggio F, Leemreis J, Groeneveld AB (2006) Biomarkers of acute renal injury and renal failure. Shock 26:245–253CrossRefPubMed
4.
go back to reference Bagshaw SM, Lapinsky S, Dial S, Arabi Y, Dodek P, Wood G, Ellis P, Guzman J, Marshall J, Parrillo JE, Skrobik Y, Kumar A (2009) Acute kidney injury in septic shock: clinical outcomes and impact of duration of hypotension prior to initiation of antimicrobial therapy. Intensive Care Med 35:871–881CrossRefPubMed Bagshaw SM, Lapinsky S, Dial S, Arabi Y, Dodek P, Wood G, Ellis P, Guzman J, Marshall J, Parrillo JE, Skrobik Y, Kumar A (2009) Acute kidney injury in septic shock: clinical outcomes and impact of duration of hypotension prior to initiation of antimicrobial therapy. Intensive Care Med 35:871–881CrossRefPubMed
5.
go back to reference Schortgen F, Lacherade JC, Bruneel F, Cattaneo I, Hemery F, Lemaire F, Brochard L (2001) Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 357:911–916CrossRefPubMed Schortgen F, Lacherade JC, Bruneel F, Cattaneo I, Hemery F, Lemaire F, Brochard L (2001) Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 357:911–916CrossRefPubMed
6.
go back to reference Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K (2008) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358:125–139CrossRefPubMed Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K (2008) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358:125–139CrossRefPubMed
7.
go back to reference Cittanova ML, Leblanc I, Legendre C, Mouquet C, Riou B, Coriat P (1996) Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet 348:1620–1622CrossRefPubMed Cittanova ML, Leblanc I, Legendre C, Mouquet C, Riou B, Coriat P (1996) Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet 348:1620–1622CrossRefPubMed
8.
go back to reference Su F, Wang Z, Cai Y, Rogiers P, Vincent JL (2007) Fluid resuscitation in severe sepsis and septic shock: albumin, hydroxyethyl starch, gelatin or ringer’s lactate-does it really make a difference? Shock 27:520–526CrossRefPubMed Su F, Wang Z, Cai Y, Rogiers P, Vincent JL (2007) Fluid resuscitation in severe sepsis and septic shock: albumin, hydroxyethyl starch, gelatin or ringer’s lactate-does it really make a difference? Shock 27:520–526CrossRefPubMed
9.
go back to reference Jungheinrich C, Scharpf R, Wargenau M, Bepperling F, Baron JF (2002) The pharmacokinetics and tolerability of an intravenous infusion of the new hydroxyethyl starch 130/0.4 (6%, 500 mL) in mild-to-severe renal impairment. Anesth Analg 95:544–551 (table of contents)CrossRefPubMed Jungheinrich C, Scharpf R, Wargenau M, Bepperling F, Baron JF (2002) The pharmacokinetics and tolerability of an intravenous infusion of the new hydroxyethyl starch 130/0.4 (6%, 500 mL) in mild-to-severe renal impairment. Anesth Analg 95:544–551 (table of contents)CrossRefPubMed
10.
go back to reference Wiedermann CJ (2008) Systematic review of randomized clinical trials on the use of hydroxyethyl starch for fluid management in sepsis. BMC Emerg Med 8:1CrossRefPubMed Wiedermann CJ (2008) Systematic review of randomized clinical trials on the use of hydroxyethyl starch for fluid management in sepsis. BMC Emerg Med 8:1CrossRefPubMed
11.
go back to reference Ragaller MJ, Theilen H, Koch T (2001) Volume replacement in critically ill patients with acute renal failure. J Am Soc Nephrol 12 Suppl 17:S33–S39PubMed Ragaller MJ, Theilen H, Koch T (2001) Volume replacement in critically ill patients with acute renal failure. J Am Soc Nephrol 12 Suppl 17:S33–S39PubMed
12.
go back to reference Boldt J, Wolf M (2008) Identification of renal injury in cardiac surgery: the role of kidney-specific proteins. J Cardiothorac Vasc Anesth 22:122–132CrossRefPubMed Boldt J, Wolf M (2008) Identification of renal injury in cardiac surgery: the role of kidney-specific proteins. J Cardiothorac Vasc Anesth 22:122–132CrossRefPubMed
13.
go back to reference Schabinski F, Oishi J, Tuche F, Luy A, Sakr Y, Bredle D, Hartog C, Reinhart K (2009) Effects of a predominantly hydroxyethyl starch (HES)-based and a predominantly non HES-based fluid therapy on renal function in surgical ICU patients. Intensive Care Med 35:1539–1547CrossRefPubMed Schabinski F, Oishi J, Tuche F, Luy A, Sakr Y, Bredle D, Hartog C, Reinhart K (2009) Effects of a predominantly hydroxyethyl starch (HES)-based and a predominantly non HES-based fluid therapy on renal function in surgical ICU patients. Intensive Care Med 35:1539–1547CrossRefPubMed
14.
go back to reference Singleton KD, Wischmeyer PE (2003) Distance of cecum ligated influences mortality, tumor necrosis factor-alpha and interleukin-6 expression following cecal ligation and puncture in the rat. Eur Surg Res 35:486–491CrossRefPubMed Singleton KD, Wischmeyer PE (2003) Distance of cecum ligated influences mortality, tumor necrosis factor-alpha and interleukin-6 expression following cecal ligation and puncture in the rat. Eur Surg Res 35:486–491CrossRefPubMed
15.
go back to reference Shinoda T, Smith CE, Khairallah PA, Fouad-Tarazi FM, Estafanous FG (1991) Effects of propranolol on myocardial performance during acute normovolemic hemodilution. J Cardiothorac Vasc Anesth 5:15–22CrossRefPubMed Shinoda T, Smith CE, Khairallah PA, Fouad-Tarazi FM, Estafanous FG (1991) Effects of propranolol on myocardial performance during acute normovolemic hemodilution. J Cardiothorac Vasc Anesth 5:15–22CrossRefPubMed
16.
go back to reference Herget-Rosenthal S, Bokenkamp A, Hofmann W (2007) How to estimate GFR-serum creatinine, serum cystatin C or equations? Clin Biochem 40:153–161CrossRefPubMed Herget-Rosenthal S, Bokenkamp A, Hofmann W (2007) How to estimate GFR-serum creatinine, serum cystatin C or equations? Clin Biochem 40:153–161CrossRefPubMed
17.
go back to reference Tenstad O, Roald AB, Grubb A, Aukland K (1996) Renal handling of radiolabelled human cystatin C in the rat. Scand J Clin Lab Invest 56:409–414CrossRefPubMed Tenstad O, Roald AB, Grubb A, Aukland K (1996) Renal handling of radiolabelled human cystatin C in the rat. Scand J Clin Lab Invest 56:409–414CrossRefPubMed
18.
go back to reference Devarajan P (2008) Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of kidney disease. Scand J Clin Lab Invest Suppl 241:89–94CrossRefPubMed Devarajan P (2008) Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of kidney disease. Scand J Clin Lab Invest Suppl 241:89–94CrossRefPubMed
19.
go back to reference Mori K, Lee HT, Rapoport D, Drexler IR, Foster K, Yang J, Schmidt-Ott KM, Chen X, Li JY, Weiss S, Mishra J, Cheema FH, Markowitz G, Suganami T, Sawai K, Mukoyama M, Kunis C, D’Agati V, Devarajan P, Barasch J (2005) Endocytic delivery of lipocalin–siderophore–iron complex rescues the kidney from ischemia–reperfusion injury. J Clin Invest 115:610–621PubMed Mori K, Lee HT, Rapoport D, Drexler IR, Foster K, Yang J, Schmidt-Ott KM, Chen X, Li JY, Weiss S, Mishra J, Cheema FH, Markowitz G, Suganami T, Sawai K, Mukoyama M, Kunis C, D’Agati V, Devarajan P, Barasch J (2005) Endocytic delivery of lipocalin–siderophore–iron complex rescues the kidney from ischemia–reperfusion injury. J Clin Invest 115:610–621PubMed
20.
go back to reference Rivers EP, Nguyen HB, Huang DT, Donnino M (2004) Early goal-directed therapy. Crit Care Med 32:314–315 (author reply 315)CrossRefPubMed Rivers EP, Nguyen HB, Huang DT, Donnino M (2004) Early goal-directed therapy. Crit Care Med 32:314–315 (author reply 315)CrossRefPubMed
21.
go back to reference Rivers EP, Coba V, Whitmill M (2008) Early goal-directed therapy in severe sepsis and septic shock: a contemporary review of the literature. Curr Opin Anaesthesiol 21:128–140CrossRefPubMed Rivers EP, Coba V, Whitmill M (2008) Early goal-directed therapy in severe sepsis and septic shock: a contemporary review of the literature. Curr Opin Anaesthesiol 21:128–140CrossRefPubMed
22.
go back to reference Wagenblast M (2004) Molmassenverteilung der in Milz und Leber gespeicherten hydroxyethylstärke (HES) bei Ratten nach intravenöser Applikation - polymeranalytische Untersuchungen mittels Kopplung der Ausschluss-Chromatographie und Mehrwinkel-Laser-Streulicht-Detektion. Deutsche Veterinärmedizinische Gesellschaft Service GmbH Wagenblast M (2004) Molmassenverteilung der in Milz und Leber gespeicherten hydroxyethylstärke (HES) bei Ratten nach intravenöser Applikation - polymeranalytische Untersuchungen mittels Kopplung der Ausschluss-Chromatographie und Mehrwinkel-Laser-Streulicht-Detektion. Deutsche Veterinärmedizinische Gesellschaft Service GmbH
23.
go back to reference Lenz K, Schimetta W, Polz W, Kroll W, Gruy-Kapral C, Magometschnigg D (2000) Intestinal elimination of hydroxyethyl starch? Intensive Care Med 26:733–739CrossRefPubMed Lenz K, Schimetta W, Polz W, Kroll W, Gruy-Kapral C, Magometschnigg D (2000) Intestinal elimination of hydroxyethyl starch? Intensive Care Med 26:733–739CrossRefPubMed
24.
go back to reference Suttner S, Boldt J (2004) Volume replacement with hydroxyethyl starch: is there an influence on kidney function? Anasthesiol Intensivmed Notfallmed Schmerzther 39:71–77CrossRefPubMed Suttner S, Boldt J (2004) Volume replacement with hydroxyethyl starch: is there an influence on kidney function? Anasthesiol Intensivmed Notfallmed Schmerzther 39:71–77CrossRefPubMed
25.
go back to reference Boldt J, Brosch C, Ducke M, Papsdorf M, Lehmann A (2007) Influence of volume therapy with a modern hydroxyethylstarch preparation on kidney function in cardiac surgery patients with compromised renal function: a comparison with human albumin. Crit Care Med 35:2740–2746CrossRefPubMed Boldt J, Brosch C, Ducke M, Papsdorf M, Lehmann A (2007) Influence of volume therapy with a modern hydroxyethylstarch preparation on kidney function in cardiac surgery patients with compromised renal function: a comparison with human albumin. Crit Care Med 35:2740–2746CrossRefPubMed
26.
go back to reference Boldt J, Brosch C, Rohm K, Papsdorf M, Mengistu A (2008) Comparison of the effects of gelatin and a modern hydroxyethyl starch solution on renal function and inflammatory response in elderly cardiac surgery patients. Br J Anaesth 100:457–464CrossRefPubMed Boldt J, Brosch C, Rohm K, Papsdorf M, Mengistu A (2008) Comparison of the effects of gelatin and a modern hydroxyethyl starch solution on renal function and inflammatory response in elderly cardiac surgery patients. Br J Anaesth 100:457–464CrossRefPubMed
27.
go back to reference Boldt J, Suttner S (2005) Plasma substitutes. Minerva Anestesiol 71:741–758PubMed Boldt J, Suttner S (2005) Plasma substitutes. Minerva Anestesiol 71:741–758PubMed
28.
go back to reference Ginz HF, Gottschall V, Schwarzkopf G, Walter K (1998) Excessive tissue storage of colloids in the reticuloendothelial system. Anaesthesist 47:330–334CrossRefPubMed Ginz HF, Gottschall V, Schwarzkopf G, Walter K (1998) Excessive tissue storage of colloids in the reticuloendothelial system. Anaesthesist 47:330–334CrossRefPubMed
29.
go back to reference Sirtl C, Laubenthal H, Zumtobel V, Kraft D, Jurecka W (1999) Tissue deposits of hydroxyethyl starch (HES): dose-dependent and time-related. Br J Anaesth 82:510–515PubMed Sirtl C, Laubenthal H, Zumtobel V, Kraft D, Jurecka W (1999) Tissue deposits of hydroxyethyl starch (HES): dose-dependent and time-related. Br J Anaesth 82:510–515PubMed
30.
go back to reference Johannes T, Mik EG, Nohe B, Raat NJ, Unertl KE, Ince C (2006) Influence of fluid resuscitation on renal microvascular PO2 in a normotensive rat model of endotoxemia. Crit Care 10:R88CrossRefPubMed Johannes T, Mik EG, Nohe B, Raat NJ, Unertl KE, Ince C (2006) Influence of fluid resuscitation on renal microvascular PO2 in a normotensive rat model of endotoxemia. Crit Care 10:R88CrossRefPubMed
31.
go back to reference Perel P, Roberts I (2007) Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev: CD000567 Perel P, Roberts I (2007) Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev: CD000567
32.
go back to reference Boldt J, Suttner S, Brosch C, Lehmann A, Rohm K, Mengistu A (2009) The influence of a balanced volume replacement concept on inflammation, endothelial activation, and kidney integrity in elderly cardiac surgery patients. Intensive Care Med 35:462–470CrossRefPubMed Boldt J, Suttner S, Brosch C, Lehmann A, Rohm K, Mengistu A (2009) The influence of a balanced volume replacement concept on inflammation, endothelial activation, and kidney integrity in elderly cardiac surgery patients. Intensive Care Med 35:462–470CrossRefPubMed
33.
go back to reference Zander R (2002) Base excess and lactate concentration in infusion solutions and blood products. Anasthesiol Intensivmed Notfallmed Schmerzther 37:359–363CrossRefPubMed Zander R (2002) Base excess and lactate concentration in infusion solutions and blood products. Anasthesiol Intensivmed Notfallmed Schmerzther 37:359–363CrossRefPubMed
34.
go back to reference Dickenmann M, Oettl T, Mihatsch MJ (2008) Osmotic nephrosis: acute kidney injury with accumulation of proximal tubular lysosomes due to administration of exogenous solutes. Am J Kidney Dis 51:491–503CrossRefPubMed Dickenmann M, Oettl T, Mihatsch MJ (2008) Osmotic nephrosis: acute kidney injury with accumulation of proximal tubular lysosomes due to administration of exogenous solutes. Am J Kidney Dis 51:491–503CrossRefPubMed
Metadata
Title
The impact of crystalloid and colloid infusion on the kidney in rodent sepsis
Authors
Martin Alexander Schick
Tobias Jobst Isbary
Nicolas Schlegel
Juergen Brugger
Jens Waschke
Ralf Muellenbach
Norbert Roewer
Christian Wunder
Publication date
01-03-2010
Publisher
Springer-Verlag
Published in
Intensive Care Medicine / Issue 3/2010
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-009-1704-0

Other articles of this Issue 3/2010

Intensive Care Medicine 3/2010 Go to the issue